Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 135

Results For "Director"

2831 News Found

Ami Organics inks agreement with Fermion for two additional APIs
News | December 18, 2023

Ami Organics inks agreement with Fermion for two additional APIs

The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25


Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries
News | December 18, 2023

Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries

10+ emerging markets, Japan & ANZ transition in final phase


Fischer Chemic to acquire Time Medical Internaitonal Ventures India
News | December 17, 2023

Fischer Chemic to acquire Time Medical Internaitonal Ventures India

Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies


Biocon Biologics recognized as an Asia IP Elite for 2023
News | December 17, 2023

Biocon Biologics recognized as an Asia IP Elite for 2023

Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list


Panacea Biotec launches EasyFourPol in India
News | December 17, 2023

Panacea Biotec launches EasyFourPol in India

Receives registration of Valganciclovir powder for oral solution in Germany


Dr. Reddy's becomes first Indian pharma company to debut on the DJSI
News | December 17, 2023

Dr. Reddy's becomes first Indian pharma company to debut on the DJSI

Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis


Ami Organics inaugurates new API manufacturing facility
News | December 17, 2023

Ami Organics inaugurates new API manufacturing facility

This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment


Zydus inks licensing agreement with Daewoong Pharmaceutical for leuprolide injectable in the US
News | December 12, 2023

Zydus inks licensing agreement with Daewoong Pharmaceutical for leuprolide injectable in the US

The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome


Astellas receives USFDA approval for expanded use of Cresemba for treatment of mucormycosis
Drug Approval | December 10, 2023

Astellas receives USFDA approval for expanded use of Cresemba for treatment of mucormycosis

Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections


ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346
News | December 10, 2023

ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346

First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes